Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)

@article{Zhou2003HumanCE,
  title={Human cardiomyocytes express high level of Na+/glucose cotransporter 1 (SGLT1)},
  author={Lubing Zhou and Ellen V. Cryan and Michael R. D'Andrea and Stanley M. Belkowski and Bruce R. Conway and Keith T. Demarest},
  journal={Journal of Cellular Biochemistry},
  year={2003},
  volume={90}
}
We have quantitatively measured gene expression for the sodium‐dependent glucose cotransporters 1 and 2 (SGLT1 and SGLT2) in 23 human tissues using the method of real time PCR. As predicted, our results revealed that the expression of SGLT1 was very high in the small intestine (1.2E + 6 molecules/μg total RNA) relative to that in the kidney (3E + 4 molecules/μg total RNA). Surprisingly, we observed that the expression of SGLT1 in human heart was unexpectedly high (3.4E + 5 molecules/μg total… 
Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members
TLDR
TaqMan™ quantitative polymerase chain reaction (PCR) analysis of SGLT2 and other sodium/glucose transporter genes on RNAs from 72 normal tissues from three different individuals consistently observe that S GLT2 is highly kidney specific while SGLSGLT5 ishighly kidney abundant.
Expression of SGLT1 in Human Hearts and Impairment of Cardiac Glucose Uptake by Phlorizin during Ischemia-Reperfusion Injury in Mice
TLDR
Cardiac SGLTs, possibly SGLT1 in particular, appear to provide an important protective mechanism against IRI by replenishing ATP stores in ischemic cardiac tissues via enhancing availability of glucose.
Cardiac Sodium-Glucose Co-Transporter 1 (SGLT1) is a Novel Mediator of Ischemia/Reperfusion Injury.
TLDR
It is found that TGSGLT1-DOWN hearts were protected from I/R injury in vivo and ex vivo, with decreased infarct size, necrosis, dysfunction, and oxidative stress, and S GLT1 may represent a novel therapeutic target for mitigating I-R injury.
SGLT2 mediates glucose reabsorption in the early proximal tubule.
TLDR
It is demonstrated that SGLT2 mediates glucose re absorption in the early proximal tubule and most of the glucose reabsorption by the kidney, overall, which mimics and explains the glucosuric phenotype of individuals carrying SLC5A2 mutations.
Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart
TLDR
Results show that heart SMIT1 senses HG and triggers NOX2 activation, which could participate in the redox signaling in hyperglycemic heart and contribute to the pathophysiology of diabetic cardiomyopathy.
Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.
TLDR
It is indicated that in rodents the expression of SGLT2 is kidney-specific and point to distinct sex and species differences in S GLT2 protein expression that cannot be explained by differences in mRNA.
SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy.
Expression profiling and immunolocalization of Na+-d-glucose-cotransporter 1 in mice employing knockout mice as specificity control indicate novel locations and differences between mice and rats
The expression and localization of sodium-d-glucose cotransporter SGLT1 (SLC5A1), which is involved in small intestinal glucose absorption and renal glucose reabsorption, is of high biomedical
Localizations of Na+-d-glucose cotransporters SGLT1 and SGLT2 in human kidney and of SGLT1 in human small intestine, liver, lung, and heart
TLDR
The newly identified locations of hS GLT1 implicate several extra renal functions of this transporter, such as fluid absorption in the lung, energy supply to Clara cells, regulation of enteroendocrine cells secretion, and release of glucose from heart capillaries, which may be blocked by reversible SGLT1 inhibitors which are under development.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 27 REFERENCES
The high affinity Na+/glucose cotransporter. Re-evaluation of function and distribution of expression.
TLDR
The primary structure, functional characterization, and tissue distribution of the high affinity Na+/glucose cotransporter SGLT1 from rat kidney are reported and its role in the reabsorption mechanism of D- glucose in the kidney is clarified.
Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium.
TLDR
The results imply that individual sodium-glucose cotransporter mRNA species are not regulated in a similar fashion, and suggests that, in addition to SGLT1 and S GLT2, glucose reabsorption by renal epithelial cells might involve additional glucose transporters such as SglT3.
Cloning of a human kidney cDNA with similarity to the sodium-glucose cotransporter.
TLDR
Low-stringency screening with the human intestinal Na(+)-glucose cotransporter S GLT1 is used to isolate a 2,271-nucleotide cDNA (Hu14) from human kidney, which is 59% identical at the amino acid level to SGLT1 and has a similar number and arrangement of predicted membrane-spanning regions.
Molecular Characteristics of Na+-coupled Glucose Transporters in Adult and Embryonic Rat Kidney *
TLDR
It is shown that expression of rat SGLT2 mRNA is kidney specific and that it is strongly and exclusively expressed in proximal tubule S1 segments, which strongly indicate that S GLT2 is the major kidney cortical low affinity glucose transporter.
The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.
The major reabsorptive mechanism for D-glucose in the kidney is known to involve a low affinity high capacity Na+/glucose cotransporter, which is located in the early proximal convoluted tubule
SAAT1 is a low affinity Na+/glucose cotransporter and not an amino acid transporter. A reinterpretation.
TLDR
It is concluded that the SAAT1 cDNA encodes a renal low affinity Na+(1)/glucose(1) cotransporter and it is proposed that pig SAat1 be renamed pSGLT2.
T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.
TLDR
With long-term T-1095 treatment, both blood glucose and HbA1c levels were reduced in STZ-induced diabetic rats and yellow KK mice, and there was amelioration of abnormal carbohydrate metabolism, i.e., hyperinsulinemia and hypertriglyceridemia, and of the development of microalbuminuria, in yellowKK mice.
Cloning of a membrane-associated protein which modifies activity and properties of the Na(+)-D-glucose cotransporter.
...
1
2
3
...